キムユンジュン (Kim Yunjung) - マイポータル

基本情報

所属: 筑波大学医学医療系助教

学位: PhD(University of Tsukuba)

J-GLOBAL ID: 201801010175723416
researchmap会員ID: B000313171

研究分野

経歴

2019年6月 - 現在

University of Tsukuba, Faculty of Medicine, Department of Diagnostic Pathology, Assistant Professor
2018年2月 - 2019年5月

University of Tsukuba, Faculty of Medicine, Department of Diagnostic Pathology, Post-doctoral fellow
2011年5月 - 2013年3月

Seoul National University Bundang Hospital, Medical Technologist
2007年12月 - 2008年2月

HanYang University Medical Center, Research Intern
2004年3月 - 2007年2月

Clinical Biomedical Laboratory, Laboratory assistant
2005年7月 - 2005年8月

Korea Research Institute of Bioscience&Biotechnology, Research Intern

学歴

2013年10月 - 2017年9月

University of Tsukuba, Department of Diagnostic Pathology, Doctor program in Biomedical Science
2009年3月 - 2011年2月

Inje University, Department of Biomedical Laboratory Science, Master program in Smart Food & Drug
2004年3月 - 2009年2月

Inje University, Department of Biomedical Laboratory Science, Undergraduate program in Biomedical Science

受賞

2013年9月

4-Year Full Scholar ship in PhD program, MEXT

キムユンジュン
2010年11月

Excellence Second prize for Oral presentation, Inje University

キムユンジュン
2009年11月

Excellence Poster Award, Inhibitory effect of epigallocatechin-3-gallate (EGCG) on activity of thromboxane A2 production-associated enzyme, Korean Society for Biomedical Laboratory Science

キムユンジュン

論文

192

Carcinogen-induced tumors in SFN-transgenic mice harbor a characteristic mutation spectrum of human lung adenocarcinoma

Cancer science 110 2431-2441 2019年6月査読有り
244

Stratifin inhibits SCFFBW7 formation and blocks ubiquitination of oncoproteins during the course of lung adenocarcinogenesis

キムユンジュン

Clinical Cancer Research 25(9) 2809-2820 2019年5月査読有り
151

DNA hypomethylation-related overexpression of SFN, GORASP2 and ZYG11A is a novel prognostic biomarker for early stage lung adenocarcinoma

キムユンジュン

Oncotarget 10(17) 1625-1636 2019年2月査読有り
241

High expression of ovarian cancer immunoreactiveantigen domain containing 2 (OCIAD2) is associated with poorprognosis in lung adenocarcinoma

Pathology International 2018年10月査読有り
312

Stratifin regulates stabilization of receptor tyrosine kinases via interaction with ubiquitin-specific protease 8 in lung adenocarcinoma

キムユンジュン

Oncogene 37 5387-5402 2018年6月
123

Ubiquitin-specific protease 8 is a novel prognostic marker in early-stage lung adenocarcinoma

Yunjung Kim, Aya Shiba-Ishii, Tomoki Nakagawa, Ryan Edbert Husni, Shingo Sakashita, Tomoyo Takeuchi, Masayuki Noguchi

PATHOLOGY INTERNATIONAL 67(6) 292-301 2017年6月
118

miR-3941: A novel microRNA that controls IGBP1 expression and is associated with malignant progression of lung adenocarcinoma

Taiki Sato, Aya Shiba-Ishii, Yunjung Kim, Tomoko Dai, Ryan Edbert Husni, JeongMin Hong, Junko Kano, Shingo Sakashita, Tatsuo Iijima, Masayuki Noguchi

CANCER SCIENCE 108(3) 536-542 2017年3月
230

DNMT3a expression pattern and its prognostic value in lung adenocarcinoma

Ryan Edbert Husni, Aya Shiba-Ishii, Shinji Iiyama, Toshihiro Shiozawa, Yunjung Kim, Tomoki Nakagawa, Taiki Sato, Junko Kano, Yuko Minami, Masayuki Noguchi

LUNG CANCER 97 59-65 2016年7月
102

Stratifin accelerates progression of lung adenocarcinoma at an early stage.

Aya Shiba-Ishii, Yunjung Kim, Toshihiro Shiozawa, Shinji Iyama, Kaishi Satomi, Junko Kano, Shingo Sakashita, Yukio Morishita, Masayuki Noguchi

Molecular cancer 14 142-142 2015年7月30日
100

Inhibitory effects of epigallocatechin-3-gallate on microsomal cyclooxygenase-1 activity in platelets

キムユンジュン

Biomolecules & therapeutics 21 54-59 2013年1月
Inhibition of platelet aggregation by chlorogenic acid via cAMP and cGMP-dependent manner

Hyun-Jeong Cho, Hee-Jin Kang, Yun-Jung Kim, Dong-Ha Lee, Hyuk-Woo Kwon, Yun-Yi Kim, Hwa-Jin Park

BLOOD COAGULATION & FIBRINOLYSIS 23(7) 629-635 2012年10月

講演・口頭発表等

OCIAD2 impairs mitochondrial-dependent apoptosis in lung adenocarcinoma cell lines

The 78th Annual meeting for the Japanese Cancer Association 2019年9月28日
Exome sequencing identifies a distinct mutational landscape in SFN-transgenic mice bearing human lung adenocarcinoma

The 78th Annual meeting for the Japanese Cancer Association 2019年9月26日
Patient-derived xenografts of lung squamous cell carcinoma show a characteristic genetic profile indicating a specific biological subtype

The 20th World Conference on Lung Cancer 2019年9月10日
OCIAD2 impairs mitochondria-mediated apoptosis through substantial alteration of crista structure in lung adenocarcinoma

The 20th World Conference on Lung Cancer 2019年9月
NNK-induced tumors in SFN-transgenic mice model harbor characteristic mutational profiles mimicking major human lung adenocarcinoma

The 16th Japanese Society of Pathology Conference for Investigate pathology 2019年8月2日
The novel SFN inhibitors Aprepitant and Ticagrelor exert anti-tumor effects through blocking of oncoprotein ubiquitination.

The 19th World Conference on Lung Cancer 2018年9月23日
The novel SFN inhibitors Aprepitant and Ticagrelor exert anti-tumor effects through blocking of oncoprotein ubiquitination.

Aya Shiba-Ishii, Takatsugu Hirokawa, Yunjung Kim, Jeongmin Hong, Masayuki, Noguchi

The 6th Japanese Cancer Association–American Association for Cancer Research special joint conference 2018年7月
Stratifin interaction with USP8 is regulated by PP1 and AKT for stabilization of EGFR in lung adenocarcinoma

Yunjung Kim, Aya Shiba-Ishii, Masayuki Noguchi

The 6th Japanese Cancer Association–American Association for Cancer Research special joint conference 2018年7月
Stratifin stabilizes oncoproteins by binding with SKP1 to block SCFfbw7 ubiquitin ligase

Jeongmin Hong, Aya Shiba-Ishii, Yunjung Kim, Masayuki Noguchi

The 6th Japanese Cancer Association–American Association for Cancer Research special joint conference 2018年1月
SFN stabilizes oncoproteins through binding with SKP1 to block SCFFBW7 Ubiquitin ligase

Jeongmin Hong, Aya Shiba-Ishii, Yunjung Kim, Masayuki Noguchi

18th World Conference on Lung Cancer 2017年10月
Stratifin regulates stabilization of receptor tyrosine kinases via activation of ubiquitin-specific protease 8 in lung adenocarcinoma

Aya Shiba-Ishii, Yunjung Kim, Masayuki Noguchi

The 18th World Conference on Lung Cancer 2017年10月
Stratifin blocks SCFfbxw7 ubiquitin ligase and induces progression of lung adenocarcinoma

Jeongmin Hong, Aya Shiba-Ishii, Yunjung Kim, Masayuki Noguchi

The 76th Annual meeting for the Japanese Cancer Association 2017年9月
Stratifin regulates stabilization of EGFR through activation of ubiquitin-specific protease 8 in lung adenocarcinoma

Yunjung Kim, Aya Shiba-Ishii, Masayuki Noguchi

The 76th Annual meeting for the Japanese Cancer Association 2017年9月
Stratifin regulates ubiquitin-specific protease 8 expression in lung adenocarcinoma

Yunjung Kim, Aya Shiba-Ishii, Tomoki Nakagawa, Shingo Sakashita, Noriyuki Nakano, Ryota Matsuoka, Masayuki Noguchi

The 106th Annual meeting for the Japanese Association of Pathology 2017年4月
miR-3941: a novel microRNA that controls IGBP1 expression and is associated with malignant progression of lung adenocarcinoma

Taiki Sato, Aya Shiba-Ishii, Yunjung Kim, Tomoko Dai, Masayuki Noguchi

The 17th World Conference on Lung Cancer 2016年12月
Stratifin associated ubiquitin-specific protease 8 stabilizes c-Met in lung adenocarcinoma

Yunjung Kim, Aya Shiba-Ishii, Masayuki Noguchi

The 75th annual meeting of the Japanese Cancer Association 2016年10月
Stratifin accelerates progression of lung adenocarcinoma at an early stage

Aya Shiba-Ishii, Yunjung Kim, Masayuki Noguchi

The 16th World Conference on Lung Cancer 2015年9月
Inhibition of EGFR lysosomal degradation in lung adenocarcinoma by ubiquitin-specific protease 8 and stratifin

Yunjung Kim, Aya Shiba-Ishii, Masayuki Noguchi

The 16th World Conference on Lung Cancer 2015年9月

キムユンジュン

基本情報

研究分野

経歴

学歴

受賞

論文

講演・口頭発表等

所属学協会

メニュー